I forgot about the trial dates promised for TRXE009 as well.
MAY 08 2015 - 10:08 AM
$NRT/Novogen’s TRXE-009 clinical trial planned for 2016 will test whether the formula can treat the incurable paediatric brain cancer DIPG (diffuse intrinsic pontine glioma).
- Forums
- ASX - By Stock
- KZA
- Share price
Share price, page-49
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)